| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JZHR1600001 | 头孢泊肟酯 | cefpodoxime proxetil | Active ingredient | Chemical Drugs | State Standards | 2016-05-10 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2016-11-10 | view |
| JYHZ0700051 | 多潘立酮 | domperidone | Active ingredient | Chemical Drugs | License Renew | 2007-04-28 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2009-09-30 | view |
| JYHS2100054 | 盐酸帕罗西汀片 | paroxetine hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-03-25 | view |
| JYHS2100053 | 盐酸帕罗西汀片 | paroxetine hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-03-25 | view |
| JYHS2100052 | 盐酸帕罗西汀片 | paroxetine hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-03-25 | view |
| JYHS2100051 | 盐酸帕罗西汀片 | paroxetine hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-03-26 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-03-25 | view |
| JYHS2100002 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-01-06 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-01-05 | view |
| JYHS2100001 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2021-01-06 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2021-01-05 | view |
| JYHS2000035 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-10-11 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-10-09 | view |
| JYHS2000034 | 米氮平片 | mirtazapine | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-10-11 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-10-09 | view |
| JYHS1900004 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JYHS1900002 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JYHS1900001 | 阿立哌唑片 | aripiprazole | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2019-01-17 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2019-01-16 | view |
| JYHS1800003 | 枸橼酸西地那非片 | sildenafil citrate | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2018-12-24 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2020-06-24 | view |
| JYHS1800002 | 泮托拉唑钠肠溶片 | pantoprazole sodium | Tablet | Chemical Drugs | Import Drug Application | 2018-10-19 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2020-12-31 | view |
| JYHS1800001 | 泮托拉唑钠肠溶片 | pantoprazole sodium | Tablet | Chemical Drugs | Import Drug Application | 2018-10-22 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2020-12-31 | view |
| JYHB1300751 | 头孢呋辛酯 | cefuroxime axetil | Active ingredient | Chemical Drugs | Supplementary Application | 2013-06-18 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | Certificate Issued | 2014-01-10 | view |
| JXHS2000070 | 盐酸缬更昔洛韦片 | valganciclovir hydrochloride | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-06-10 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-06-09 | view |
| JXHS2000063 | 孟鲁司特钠咀嚼片 | montelukast sodium | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-06-10 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-06-09 | view |
| JXHS2000062 | 孟鲁司特钠咀嚼片 | montelukast sodium | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2020-06-10 | 阿拉宾度制药有限公司 | Aurobindo Pharma Ltd | In Review | 2020-06-09 | view |